Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization

Laboratory Investigation

Volumn 83, Issue 1, 2003, Pages 65-73

  Akita, Takako ^a   Murohara, Toyoaki ^a,b,c   Ikeda, Hisao ^a   Sasaki, Ken ichiro ^a   Shimada, Toshifumi ^a   Egami, Kimiyasu ^a   Imaizumi, Tsutomu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CELL MARKER; GENISTEIN; NEUTRALIZING ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR; SU 1498; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINEAGE; CELL MIGRATION; CELL SURFACE; CELL TRANSPLANTATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG EFFICACY; ENDOTHELIUM CELL; HEART INFARCTION PREVENTION; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IMMUNE DEFICIENCY; MALE; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

EID: 0037239301     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000050761.67879.E4     Document Type: Article

References (32)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, and Isner JM (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
3. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, and Isner JM (1996). Hypoxia-induced paracrine regulation of VEGF receptor expression. J Clin Invest 97:469-476.
4. Carmeliet P (2000). Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
5. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, and Albelda SM (1997). Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677.
6. Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-30.
7. Garlanda C and Dejana E (1997). Heterogeneity of endothelial cells: Specific markers. Arterioscler Thromb Vasc Biol 17:1193-1202.
8. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, and Gastl G (2000). Evidence from a leukemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355:1688-1691.
9. Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T, and Shimada K (2000). Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 35:968-973.
10. Isner JM and Asahara T (1999). Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231-1236.
11. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427.
12. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, Tabayashi K, Shibuya M, and Sato Y (2000). Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 19:2138-2146.
13. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
14. Lin Y, Weisdorf DJ, Solovey A, and Hebbel RP (2000). Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77.
15. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, and Ullrich A (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
16. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM (1998a). Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567-2578.
17. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, and Isner JM (1998b). Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97:99-107.
18. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki Ki, Eguchi H, Onitsuka I, Matsui K, and Imaizumi T (2000). Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105:1527-1536.
19. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, and Isner JM (1999). Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 19:1156-1161.
20. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, and Isner JM (1995). Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270:31189-31195.
21. Risau W (1995). Differentiation of endothelium. FASEB J 9:926-933.
22. Risau W (1997). Mechanisms of angiogenesis. Nature 386:671-674.
23. Shen BQ, Lee DY, Gerber HP, Keyt BA, Ferrara N, and Zioncheck TF (1998). Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273:29979-29985.
24. Shen BQ, Lee DY, and Zioncheck TF (1999). Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274:33057-33063.
25. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, and Imaizumi T (2001a). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779.
26. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, and Imaizumi T (2001 b). Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103:897-903.
27. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
28. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
29. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, and Imaizumi T (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 360:427-435.
30. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, and Isner JM (1997). Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 3:879-886.
31. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, and Dimmeler S (2001). Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103:2885-2890.
32. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, and Rossant J (1993). Flk-1, and flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-498.